Affordable Access

[Effects of siltuximab on the interleukin-6/Stat3 signaling pathway in ovarian cancer].

Authors
  • Guo, Yu-qi
  • Lu, Ping
  • Duan, Zhen-feng
  • Zhang, Zhan
Type
Published Article
Journal
Zhonghua fu chan ke za zhi
Publication Date
Nov 01, 2010
Volume
45
Issue
11
Pages
854–859
Identifiers
PMID: 21211286
Source
Medline
License
Unknown

Abstract

These results demonstrated that siltuximab effectively block the IL-6 signaling pathways, which. Blockage of IL-6 signaling may provide benefits for the treatment of ovarian cancer.

Report this publication

Statistics

Seen <100 times